Medicine in Novel Technology and Devices最新文献

筛选
英文 中文
Estimating pulmonary arterial pressure from 4D flow images 从四维血流图像估计肺动脉压
Medicine in Novel Technology and Devices Pub Date : 2025-02-22 DOI: 10.1016/j.medntd.2025.100354
Chi Zhang , Yaowen Dong , Tongxi Liu , Jin She , Jian Yang , Deyu Li , Sheng Xie
{"title":"Estimating pulmonary arterial pressure from 4D flow images","authors":"Chi Zhang ,&nbsp;Yaowen Dong ,&nbsp;Tongxi Liu ,&nbsp;Jin She ,&nbsp;Jian Yang ,&nbsp;Deyu Li ,&nbsp;Sheng Xie","doi":"10.1016/j.medntd.2025.100354","DOIUrl":"10.1016/j.medntd.2025.100354","url":null,"abstract":"<div><div>The non-invasive method for estimating the pulmonary arterial pressure (PAP) plays an important role in the screening and diagnosis of pulmonary arterial hypertension (PAH). We aimed to establish a phase-contrast magnetic resonance imaging (PC-MRI) based method to estimate PAP. Through analyzing a patient's morphologic and hemodynamic features, this method could be used to identify PAH, and provide diagnostic and grading information for PAH. We selected 39 study participants, comprising 18 healthy volunteers and 21 patients with PAH. Morphologic and hemodynamic parameters of each participant's pulmonary arteries were obtained from 4D Flow images. Hemodynamic features were performed selected by principal component analysis (PCA). PAH identification model was built with binary logistic regression. Furthermore, A multiple linear regression (MLR) model was developed to estimate PAP, the accuracy of which was evaluated by comparing it with the value measured by right heart catheterization (RHC). PAH identification was achieved with high accuracy, using the features of pulmonary arterial morphology or blood flow velocity (BFV). Compared with RHC, MLR results showed that using pulmonary arterial morphology and BFV features in combination can greatly improve the accuracy of PAP estimation. Our results showed that the mean relative error of PAP estimation in PAH patients could reach &lt;10 ​%. A highly accurate PC-MRI based method for PAH identification and PAP estimation was successfully established. Using hemodynamic features of the pulmonary artery could improve PAP estimation accuracy, which highlights the importance of hemodynamic evaluation of pulmonary arteries in the screening and diagnosis of PAH.</div></div>","PeriodicalId":33783,"journal":{"name":"Medicine in Novel Technology and Devices","volume":"26 ","pages":"Article 100354"},"PeriodicalIF":0.0,"publicationDate":"2025-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143520107","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Differences in gait dynamic stability of healthy subjects due to age, body mass, height, BMI, and walking speed 年龄、体重、身高、BMI和步行速度对健康受试者步态动态稳定性的影响
Medicine in Novel Technology and Devices Pub Date : 2025-02-21 DOI: 10.1016/j.medntd.2025.100355
Anam Raza , Imran Mahmood , Tayyaba Sultana , Salma Sultana
{"title":"Differences in gait dynamic stability of healthy subjects due to age, body mass, height, BMI, and walking speed","authors":"Anam Raza ,&nbsp;Imran Mahmood ,&nbsp;Tayyaba Sultana ,&nbsp;Salma Sultana","doi":"10.1016/j.medntd.2025.100355","DOIUrl":"10.1016/j.medntd.2025.100355","url":null,"abstract":"<div><div>Gait deformities are usually assessed by comparing patients' data with healthy subjects. However, the variability among healthy subjects due to age, body mass, height, BMI, and walking speed could influence the baseline data and hence rehabilitation measurements. Recent studies reported gait variability among healthy subjects considering age as a variant. The independent effect of other variants such as body mass, height, BMI, and walking speed on variability in the baseline data has remained unknown, hence investigated in this study. The centre of pressure signals collected from 205 male subjects was categorised for each of the mentioned five variants. Gait variability was evaluated in terms of walking stability. The centre of pressure signals was analysed by applying Nyquist and Bode methods to compute walking stability during the gait loading and unloading phases. A statistical comparison (one-way ANOVA, p ​&lt; ​0.05) revealed significant variability in the baseline data for variables (age, height, walking speed) during the loading phase and in the anterior-posterior direction. In the medial-lateral direction, these differences were observed as significant during both loading (age, body mass, speed) and unloading phases (age, body mass, height). Overall, the subgroups in respective variants i.e. age: 27 ​± ​0.8yr, body mass: 73 ​± ​0.4 ​kg, height: 177 ​± ​0.5 ​cm, and walking speed: 1.42 ​± ​0.01 ​m/s exhibited relatively higher stability. Further, the Pearson correlation illustrated a signification stability relationship between body mass and other variants. This study provides evidence that the diversity in the healthy subjects’ composition can cause uncertainty in diagnostic and rehabilitation measurements, which is important to consider in gait evaluations.</div></div>","PeriodicalId":33783,"journal":{"name":"Medicine in Novel Technology and Devices","volume":"26 ","pages":"Article 100355"},"PeriodicalIF":0.0,"publicationDate":"2025-02-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143520108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corchorus olitorius (Jute) fiber enforced sustainable polymeric dressing material for antimicrobial activity 黄麻纤维增强抗菌活性的可持续高分子敷料
Medicine in Novel Technology and Devices Pub Date : 2025-02-01 DOI: 10.1016/j.medntd.2025.100352
Gupta Swati Sanjaykumar , Rishabha Malviya , Dhanalekshmi Unnikrishnan Meenakshi , Sathvik Belagodu Sridhar
{"title":"Corchorus olitorius (Jute) fiber enforced sustainable polymeric dressing material for antimicrobial activity","authors":"Gupta Swati Sanjaykumar ,&nbsp;Rishabha Malviya ,&nbsp;Dhanalekshmi Unnikrishnan Meenakshi ,&nbsp;Sathvik Belagodu Sridhar","doi":"10.1016/j.medntd.2025.100352","DOIUrl":"10.1016/j.medntd.2025.100352","url":null,"abstract":"<div><div>Drug delivery to wounds has developed over time from the rudimentary administration of medication on the wound or the site of infection to more sophisticated drug delivery systems. For effectively and rapidly curing wounds, a diverse range of anti-bacterial drug delivery systems must be developed. The current study investigates the possibility of using an inexpensive and environment-friendly sustainable <em>Corchorus olitorius</em> fiber (COF) as a drug carrier for the antibacterial drug tetracycline HCl and its potential as a dressing material. The fibers were purified, grafted using acrylamide monomer, and tested for SEM, FT-IR, TGA, swelling index, swelling-de- swelling behavior, and chemical resistance. Drug loading was carried out, the highest drug loading percentage was found at 99.97 ​% and the formulation released medication according to the Baker-Lonsdale release kinetics pattern. The anti-microbial study showed effective inhibition of Staphylococcus aureus. The study demonstrates the successful synthesis and application of acrylamide-grafted COF loaded with tetracycline HCl, showcasing its potential as an effective wound dressing for wound care and management. Corchorus olitorius fiber is a cost-effective and eco-friendly material for preparing medicated polymeric dressings.</div></div>","PeriodicalId":33783,"journal":{"name":"Medicine in Novel Technology and Devices","volume":"25 ","pages":"Article 100352"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143297054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The history, current state and future possibilities of the non-invasive brain computer interfaces 非侵入性脑机接口的历史、现状和未来可能性
Medicine in Novel Technology and Devices Pub Date : 2025-02-01 DOI: 10.1016/j.medntd.2025.100353
Frederico Caiado, Arkadiy Ukolov
{"title":"The history, current state and future possibilities of the non-invasive brain computer interfaces","authors":"Frederico Caiado,&nbsp;Arkadiy Ukolov","doi":"10.1016/j.medntd.2025.100353","DOIUrl":"10.1016/j.medntd.2025.100353","url":null,"abstract":"<div><div>This study explores the history and current state of Brain-Computer Interfaces (BCIs), focusing on non-invasive, EEG-based devices. BCIs have evolved from early studies in neurophysiology to real-world applications that convert brain impulses into executable commands. The study discusses the two main categories of BCIs: invasive and non-invasive, highlighting their benefits and limitations. Invasive BCIs provide precise signals but carry higher risks and ethical concerns, while non-invasive BCIs are safer but face challenges with signal deterioration and external noise. The study also evaluates the potential of wider use and availability of non-invasive interfaces by analysing their existing capabilities, limits, and potential future developments. Solutions to overcome technological and ethical challenges are explored to improve usability, user experience, and impact in areas such as healthcare, rehabilitation, entertainment, and cognitive enhancement.</div></div>","PeriodicalId":33783,"journal":{"name":"Medicine in Novel Technology and Devices","volume":"25 ","pages":"Article 100353"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143297052","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diabetes mellitus: The pathophysiology as a canvas for management elucidation and strategies 糖尿病:病理生理学作为管理阐明和策略的画布
Medicine in Novel Technology and Devices Pub Date : 2025-01-30 DOI: 10.1016/j.medntd.2025.100351
Franklyn Nonso Iheagwam , Olawumi Toyin Iheagwam
{"title":"Diabetes mellitus: The pathophysiology as a canvas for management elucidation and strategies","authors":"Franklyn Nonso Iheagwam ,&nbsp;Olawumi Toyin Iheagwam","doi":"10.1016/j.medntd.2025.100351","DOIUrl":"10.1016/j.medntd.2025.100351","url":null,"abstract":"<div><div>Diabetes mellitus (DM) is a progressive metabolic disease characterised by high blood glucose due to autoimmune destruction of the β-islet of Langerhans or gradual development of insulin resistance and β-cell degeneration. Numerous risk factors, from genetic to environmental, are associated with this disease. Based on the global observed cases and etiopathogenesis, DM falls into three broad categories: type 1, 2, and gestational diabetes mellitus. A comprehensive search was used to identify relevant publications using targeted keywords associated with DM, pathophysiology, medication, characterised compounds, and others across prominent databases like PubMed, Scopus, and Web of Science. This review examines how DM pathophysiology influences the type of diagnosis, screening, treatment, and management regimen that is implemented. The link between DM and some mechanistic factors and activated glucose metabolic changes is discussed. Insights on the medications targeting various DM pathophysiology mechanisms, antidiabetic mechanisms of characterised compounds from natural products and computer-aided identification of antidiabetics from natural sources are reviewed. These findings could lay the groundwork for inventive therapeutic strategies and leads from natural products based on the proper elucidation of antidiabetic mechanisms, thereby improving management and the impact of DM.</div></div>","PeriodicalId":33783,"journal":{"name":"Medicine in Novel Technology and Devices","volume":"25 ","pages":"Article 100351"},"PeriodicalIF":0.0,"publicationDate":"2025-01-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143297053","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development and validation of a multiplex RT-qPCR method for the simultaneous detection of influenza type A, B and SARS-COV-2 viruses 同时检测甲型流感、乙型流感和SARS-COV-2病毒的多重RT-qPCR方法的建立和验证
Medicine in Novel Technology and Devices Pub Date : 2025-01-22 DOI: 10.1016/j.medntd.2025.100350
Samira Karimkhani , Ehsan Lotfi , Fatemeh Karamali , Mahsa DarestaniFarahani , Reza Keikha , Mahmood Barati
{"title":"Development and validation of a multiplex RT-qPCR method for the simultaneous detection of influenza type A, B and SARS-COV-2 viruses","authors":"Samira Karimkhani ,&nbsp;Ehsan Lotfi ,&nbsp;Fatemeh Karamali ,&nbsp;Mahsa DarestaniFarahani ,&nbsp;Reza Keikha ,&nbsp;Mahmood Barati","doi":"10.1016/j.medntd.2025.100350","DOIUrl":"10.1016/j.medntd.2025.100350","url":null,"abstract":"<div><div>The study aimed to evaluate the diagnosis between SARS-COV-2 and influenza viruses using the Multiplex qPCR molecular method, highlighting the importance of these methods in disease management.</div><div>In this study, primers and probes were designed for the hemagglutinin region (HA) of influenza A, the M region of influenza B virus, and the RdRp region of SARS-COV-2. Optimization was performed using qPCR methods, and the method's analytical sensitivity and specificity were assessed. Finally, the process was compared to the commercial kit, Generi-Biotech Company (GB SARS-CoV-2 Influenza A/B).</div><div>The best annealing temperature for this method was determined to be 58 ​°C. Analytical sensitivity showed detection limits of 500 copies of the virus genome for SARS-CoV-2, 250 copies for influenza A, and 500 copies for influenza B. Clinical evaluations confirmed that the designed kit exhibited 100 ​% sensitivity and specificity, identical to the GB commercial kit, establishing its comparable diagnostic performance.</div></div>","PeriodicalId":33783,"journal":{"name":"Medicine in Novel Technology and Devices","volume":"25 ","pages":"Article 100350"},"PeriodicalIF":0.0,"publicationDate":"2025-01-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143159481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GeneXAI: Influential gene identification for breast cancer stages using XAI-based multi-modal framework GeneXAI:使用基于xai的多模态框架鉴定乳腺癌分期的影响基因
Medicine in Novel Technology and Devices Pub Date : 2024-12-27 DOI: 10.1016/j.medntd.2024.100349
Sweta Manna, Sujoy Mistry, Debashis De
{"title":"GeneXAI: Influential gene identification for breast cancer stages using XAI-based multi-modal framework","authors":"Sweta Manna,&nbsp;Sujoy Mistry,&nbsp;Debashis De","doi":"10.1016/j.medntd.2024.100349","DOIUrl":"10.1016/j.medntd.2024.100349","url":null,"abstract":"<div><div>To provide improved treatment prediction and prognosis, analysis of the categorization of cancer stages and important genes in each stage is necessary. The study introduces a GeneXAI multi-modal approach, which classifies the cancer stages and identifies the influential genes by the explainable artificial intelligence models. In the first phase of the GeneXAI, a hybrid optimal feature selection method is applied to extract the imperative features using an early fusion technique. By using the imperative features, the stages of tumor, lymph nodes, and metastasis are identified, and finally, the accurate stage of cancer is classified. In the second phase, XAI such as SHAP and LIME has been utilized to identify the best genes for distinct cancer stages. Moreover, the genomic dataset's top genes were found using SHAP, while crucial genes were found by instance using LIME. Some influential genes such as (PLA2G10, MST1R F13B, and CAMK1) identified by the GeneXAI model, have also been recognized as equally important genes in the state-of-the-art biological models. The model illustrates the process of classifying the influential genes as prognostic or non-prognostic based on their clinical importance. The proposed framework achieves an average 5–7% higher accuracy than other state-of-the-art models by using the early fusion technique of a multi-modal approach.</div></div>","PeriodicalId":33783,"journal":{"name":"Medicine in Novel Technology and Devices","volume":"25 ","pages":"Article 100349"},"PeriodicalIF":0.0,"publicationDate":"2024-12-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143159778","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CAR-T cell a potential platform for cancer therapy CAR-T细胞是癌症治疗的潜在平台
Medicine in Novel Technology and Devices Pub Date : 2024-12-17 DOI: 10.1016/j.medntd.2024.100348
Azad Kumar Maurya , Shivani Saraf , Laxmikant Gautam , Rajeev Sharma
{"title":"CAR-T cell a potential platform for cancer therapy","authors":"Azad Kumar Maurya ,&nbsp;Shivani Saraf ,&nbsp;Laxmikant Gautam ,&nbsp;Rajeev Sharma","doi":"10.1016/j.medntd.2024.100348","DOIUrl":"10.1016/j.medntd.2024.100348","url":null,"abstract":"<div><div>Chimeric antigen receptor (CAR) T-cell therapy has emerged as a viable treatment for various types of cancers, including B-cell lymphoma and leukemia. CAR-T cells use genetically engineered T lymphocytes that are retargeted to destroy cancer cells using Chimeric Antigen Receptor (CAR). CARs are modular synthetic receptor that consists of three major components: (1) ectodomain, (2) transmembrane domain, and (3) endo-domain. This review discussed the evolution of CAR-T cell, the mechanism of CAR T-cell for cancer treatment, and the application of CAR T-cell therapy for different types of cancer such as lung cancer, breast cancer, ovarian cancer, renal cancer, prostate cancer, pancreatic cancer, and brain cancer. At the last, we have also discussed the clinical approach and patents of CAR-T cells.</div></div>","PeriodicalId":33783,"journal":{"name":"Medicine in Novel Technology and Devices","volume":"25 ","pages":"Article 100348"},"PeriodicalIF":0.0,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143159482","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Blastocyst cavity expansion promotes DNA methylation during early development of mouse embryos 在小鼠胚胎早期发育过程中,囊胚腔扩张促进DNA甲基化
Medicine in Novel Technology and Devices Pub Date : 2024-12-17 DOI: 10.1016/j.medntd.2024.100347
Zheng Guo, Jing Du
{"title":"Blastocyst cavity expansion promotes DNA methylation during early development of mouse embryos","authors":"Zheng Guo,&nbsp;Jing Du","doi":"10.1016/j.medntd.2024.100347","DOIUrl":"10.1016/j.medntd.2024.100347","url":null,"abstract":"<div><div>DNA methylation is an important epigenetic modification that plays a key role in the complex process of mouse embryonic development. The blastocyst cavity expansion is crucial during the second cell fate specification in mouse embryos, yet its impact on DNA methylation remains unclear. In this study, we investigate the effects of blastocyst cavity expansion on DNA methylation through two different methods: hypertonic exposure or disruption of TE (Trophectoderm) cortical tension. We found that inhibition of the blastocyst cavity expansion, either through hypertonic exposure or through disruption of TE cortical tension, suppresses the level of 5 ​MC (5-Methylcytosine) marker of DNA methylation. As a key upstream regulator of 5 ​MC, the expression variance of DNMT3L (DNA methyltransferase 3-like protein) is similar to that of 5 ​MC during the embryonic stages E2.5 to E3.5. This study reveals the function of mechanical behavior of embryos in the epigenetic modification of early mammalian embryos.</div></div>","PeriodicalId":33783,"journal":{"name":"Medicine in Novel Technology and Devices","volume":"25 ","pages":"Article 100347"},"PeriodicalIF":0.0,"publicationDate":"2024-12-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143159777","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cover 封面
Medicine in Novel Technology and Devices Pub Date : 2024-12-01 DOI: 10.1016/S2590-0935(24)00060-2
{"title":"Cover","authors":"","doi":"10.1016/S2590-0935(24)00060-2","DOIUrl":"10.1016/S2590-0935(24)00060-2","url":null,"abstract":"","PeriodicalId":33783,"journal":{"name":"Medicine in Novel Technology and Devices","volume":"24 ","pages":"Article 100344"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143138444","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信